- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Modular Medical, Inc.: Registration is Now Open for Tribe Public's CEO Presentation and Q&A Webinar Event Titled 'The Road To Revenue: Modular Medical's Strategy For Launching Pivot' Featuring Modular Medical CEO - Friday, September 4, 2026 | 331 | ACCESS Newswire | Meet with Modular Medical CEO Jeb Besser.Discover The Pivot tubeless patch pump, a simple, wearable insulin delivery platform designed to provide continuous subcutaneous insulin infusion with both basal... ► Artikel lesen | |
| Mi | 6 After-Hours Healthcare Gainers: Universe Pharma, BioAffinity, Modular Medical, Telix Pharma & More | 484 | AFX News | BEIJING (dpa-AFX) - Today's after-hours gainers in the healthcare sector included Universe Pharmaceuticals, which drew attention after disclosing multiple Schedule 13G filings; bioAffinity Technologies... ► Artikel lesen | |
| 14.08. | Modular Medical, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 05.08. | Modular Medical, Inc.: Modular Medical to Participate in the Association of Diabetes Care & Education Specialists 2026 Annual Conference | 348 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / August 5, 2026 / Modular Medical, Inc ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial... ► Artikel lesen | |
| MODULAR MEDICAL Aktie jetzt für 0€ handeln | |||||
| 04.08. | Modular Medical to initiate first phase of Pivot pump launch in October | 1 | MassDevice | ||
| 03.08. | Modular Medical, Inc.: Modular Medical Announces Launch of Pivot Insulin Delivery System Across Five Key U.S. Markets Beginning October 2026 | 421 | ACCESS Newswire | First Phase of Strategic Rollout Targets Markets with Leading Insulin Pump Prescribers and Strong New Pump Adoption. Inizio will Provide Commercialization Expertise to Accelerate Awareness and Adoption... ► Artikel lesen | |
| 23.07. | Modular Medical forms advisory council for Pivot insulin pump | 3 | Investing.com | ||
| 23.07. | Modular Medical, Inc.: Modular Medical Announces Formation of Pivot Innovation Council and Appointment of Robert Gabbay, MD, PhD, FACP as Chairman | 314 | ACCESS Newswire | - Council to Provide Strategic Clinical Guidance on Commercialization, Patient Identification, Workflow Integration, and Evidence Generation SAN DIEGO, CA / ACCESS Newswire / July 23, 2026 / Modular... ► Artikel lesen | |
| 17.07. | Modular Medical inks IMO Health collab for insulin pump EHR integration | 2 | MassDevice | ||
| 16.07. | Modular Medical partners with IMO Health on patient identification tool | 5 | Investing.com | ||
| 16.07. | Modular Medical und IMO Health entwickeln Algorithmus zur Identifizierung von Diabetespatienten | 2 | Investing.com Deutsch | ||
| 16.07. | Modular Medical, Inc.: Modular Medical and IMO Health Launch Strategic Pilot to Enable Real Time Insulin Pump Patient Identification Into Electronic Health Records | 361 | ACCESS Newswire | Pilot Combines Clinician Guided Phenotypes with IMO Health's Unique Terminology Identifiers to Help Clinicians Easily Identify Patients Most Likely to Benefit from Pivot Insulin Pump TherapyAdvancing... ► Artikel lesen | |
| 15.07. | Modular Medical, Inc.: Modular Medical Receives Research Demonstrating Positive Payor Reception of Pivot Tubeless Patch Pump | 258 | ACCESS Newswire | Completed Independent Study Strongly Supports Favorable Payor Receptivity to Pivot's Differentiated Design and Simplified User Experience, and provides further validation of significant progress towards... ► Artikel lesen | |
| 14.07. | Modular Medical, Inc.: Modular Medical Announces Completion of Research Initiative Indicating Strong Interest in Simpler Insulin Delivery | 465 | ACCESS Newswire | 97% of Surveyed Injection Users Would Consider Pump Therapy - if Easier to Learn and Improved OutcomesConducting Additional Research Initiative in Conjunction with Commercialization of the Pivot Tubeless... ► Artikel lesen | |
| 01.07. | Modular Medical reicht Software-Verbesserungen für Pivot-System bei FDA ein | 2 | Investing.com Deutsch | ||
| 01.07. | Modular Medical, Inc.: Modular Medical Announces FDA Submission of Pivot Tubeless Insulin Patch Pump Enhancements | 334 | ACCESS Newswire | Submission Covers Software Enhancements for Patient Flexibility and Customization of Pivot SAN DIEGO, CA / ACCESS Newswire / July 1, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company")... ► Artikel lesen | |
| 30.06. | Modular Medical startet kommerzielle Einführung seiner Insulinpumpe | 5 | Investing.com Deutsch | ||
| 30.06. | Modular Medical begins commercial insulin pump deployment | 2 | Investing.com | ||
| 30.06. | Modular Medical, Inc.: Modular Medical Delivers Insulin to First Patients on Pivot Tubeless Insulin Patch Pump | 430 | ACCESS Newswire | First Patients Began Device Training and Insulin Delivery Today, Marking Transition to a Commercial CompanyPivot is the First Insulin Pump Designed to Address the Large, Underserved Population of Insulin-Dependent... ► Artikel lesen | |
| 30.06. | EXCLUSIVE: Modular Medical Advances Commercial Rollout With First Active Users Of Pivot Insulin Pump | 2 | Benzinga.com |
1 2 3 Weiter >>
57 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEALWELL AI | 0,494 | -1,10 % | Healwell AI Inc: Healwell AI to roll out Smart tools on Iowa HIE | ||
| LIFEWARD | 7,260 | 0,00 % | Lifeward Ltd.: Lifeward Appoints Josh Hexter Interim Chief Executive Officer and Rami Aviram Chief Financial Officer | HUDSON, Mass. and YOKNEAM ILLIT, Israel, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a diversified biomedical innovation company with a portfolio... ► Artikel lesen | |
| IMUNON | 1,380 | 0,00 % | Imunon, Inc.: IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer | Enrollment momentum exceeding expectations is based on highly promising survival (OS) data and well tolerated safety profile demonstrated in the Company's large, randomized Phase II study, OVATION... ► Artikel lesen | |
| INSPIREMD | 0,655 | -8,39 % | InspireMD Inc.: InspireMD Appoints Carotid Intervention Commercial Leader Kathleen Kennedy as Senior Vice President of Global Sales and Marketing | MIAMI, July 30, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) ("InspireMD" or the "Company"), developer of the CGuard Prime carotid stent system for the prevention of stroke, today announced... ► Artikel lesen | |
| MYOMO | 1,172 | -4,09 % | Myomo expects $45M-$47M full-year revenue while targeting second-half cash burn below $2M | ||
| GT BIOPHARMA | 0,283 | 0,00 % | GT Biopharma, Inc.: GT Biopharma Reports Second Quarter 2026 Financial Results | Phase 1 trial evaluating GTB-3650 TriKE- remains ongoing, with an update anticipated in 2H 2026 Phase 1 basket trial evaluating GTB-5550 TriKE- in multiple solid tumor types known to express B7-H3... ► Artikel lesen | |
| INOGEN | 4,680 | +0,43 % | Inogen (INGN) Cuts Guidance Even As Profitability Climbs | ||
| INTELLIGENT BIO SOLUTIONS | 2,470 | 0,00 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission | NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing... ► Artikel lesen | |
| GLUCOTRACK | 3,520 | 0,00 % | Glucotrack, Inc. Announces Reverse Stock Split | 1-for-15 reverse stock split to become effective as of the opening of trading on August 31, 2026
RUTHERFORD, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)--Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack"... ► Artikel lesen | |
| LENSAR | 8,480 | -0,24 % | LENSAR, Inc.: LENSAR Reports First Quarter 2026 Results and Provides Business Update | 7 ALLY Robotic Cataract Laser Systems® ("ALLY System") Placements in First Quarter 2026; Backlog of 11 ALLY Systems as of March 31, 2026 First Quarter Recurring Revenue was $12.6 million Total Laser... ► Artikel lesen | |
| LEXARIA BIOSCIENCE | 13,500 | +2,23 % | Lexaria Bioscience Corp.: Lexaria Receives USD$2.6 Million Tax Rebate Payment | Lexaria's 2025 Australian human study results in a USD$2.6 million cash rebate KELOWNA, BC / ACCESS Newswire / September 1, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or the "Company")... ► Artikel lesen | |
| INCANNEX HEALTHCARE | 3,220 | -1,53 % | Incannex Healthcare: Incannex Announces First Patient Dosed in DReAMzz Phase 2 Study of IHL-42X | NEW YORK and MELBOURNE, Australia, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) ("Incannex" or the "Company"), a clinical-stage biopharmaceutical company developing innovative... ► Artikel lesen | |
| HEARTBEAM | 0,450 | +0,02 % | HeartBeam schließt Aktienverkaufsvereinbarung über 25 Millionen US-Dollar mit Titan Partners | ||
| MINIMED GROUP | 20,805 | +1,54 % | Biotech Stocks At 52-Week Highs - MiniMed Group +10%, Pulse Biosciences, Solventum, Royalty Pharma, Apogee Therapeutics | WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on September 1, 2026, as various companies reported financial results and reached certain regulatory milestones.MiniMed... ► Artikel lesen | |
| JIN MEDICAL INTERNATIONAL | 2,140 | +1,90 % | JIN MEDICAL INTERNATIONAL LTD. Reports First Half of Fiscal Year 2026 Financial Results | CHANGZHOU, China, Aug. 4, 2026 /PRNewswire/ -- JIN MEDICAL INTERNATIONAL LTD. (Nasdaq: ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated... ► Artikel lesen |
Das Unternehmen MODULAR MEDICAL INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 3,550 Euro und damit +2,60 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MODULAR MEDICAL INC finden Sie auf Wallstreet Online.